Sydney Lupkin
speaker
938 appearances
93 recordings
3 series
first heard Dec 2024
last heard 6 Sep
Sydney Lupkin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 78 in all, peaking in Jul 2026 with 21.
Appearances
has details.
matched
The president says the nine new companies include Sun Pharma, which makes generic drugs, and CSL, which makes therapies for people with rare diseases.
matched
But at least one of the companies announced today, Teva Pharmaceuticals, told investors it's still working on a deal.
matched
These agreements typically include selling some drugs on Trump RX at a discount, lower prices for Medicaid, and a commitment to build manufacturing infrastructure in the US.
matched
In exchange, the drug companies get a reprieve from certain tariffs.
matched
However, the text of the agreements has not been made public.
matched
Sydney Lefkin and PR News.
matched
Between 2022 and 2024, GLP 1 usage rose about 140%.
Over the same time, bariatric surgery fell 34%.
That's just one of the ways GLP1 drugs are changing the healthcare landscape, says Robin Wentzel, head of Wells Fargo Industry Insights.
She says GLP one drugs have been a disruptor.
In twenty twenty two, just one percent of the drugs in companies' pipelines were GLP ones.
Now it's a quarter of them.
Sydney Lupkin and PR News.
Between 2022 and 2024, GLP1 usage rose about 140%.
Over the same time, bariatric surgery fell 34%.
She says GLP1 drugs have been a disruptor.
For the pharmaceutical industry, her team found that oncology is also no longer considered the most valuable therapeutic category for new drugs.
In 2022, just one percent of the drugs in companies' pipelines were GLP1s.
Now it's a quarter of them.
Showing 41–60 of 938 · page 3 of 47
← Previous
Next →